Carillon Tower Advisers Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$101M |
| 2 |
Voya Financial
VOYA
|
+$45M |
| 3 |
Arista Networks
ANET
|
+$44.5M |
| 4 |
Atmos Energy
ATO
|
+$41M |
| 5 |
Everest Group
EG
|
+$35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HealthEquity
HQY
|
+$34.8M |
| 2 |
Royal Caribbean
RCL
|
+$33.2M |
| 3 |
Omnicell
OMCL
|
+$29.2M |
| 4 |
Tyler Technologies
TYL
|
+$29.1M |
| 5 |
Cognex
CGNX
|
+$28.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.54% |
| 2 | Technology | 17.46% |
| 3 | Industrials | 16.92% |
| 4 | Consumer Discretionary | 15.93% |
| 5 | Financials | 10.9% |
Similar funds
Carillon Tower Advisers's Q1 2018 Portfolio in Review
As of Q1 2018, Carillon Tower Advisers held 489 positions worth $12.9B, up 136,756% from $9.4M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Carillon Tower Advisers deployed $2.44B of net new capital in Q1 2018, opening 192 new positions and adding to 92 existing holdings. Its largest new stake was Voya Financial: 871,250 shares worth $4.4M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was HealthEquity, an estimated $34.8M trimmed.
- Carillon Tower Advisers's largest Q1 2018 buy was Voya Financial: 871,250 shares worth $4.4M.
- Carillon Tower Advisers added most to DXC Technology in Q1 2018, an estimated $101M increase.
- Carillon Tower Advisers's biggest Q1 2018 reduction was HealthEquity, cutting an estimated $34.8M.
- Carillon Tower Advisers fully exited Prestige Consumer Healthcare in Q1 2018, selling an estimated $404K.
- Carillon Tower Advisers's ten largest holdings make up 13% of its $12.9B portfolio in Q1 2018.
- Carillon Tower Advisers opened 192 new positions and closed 35 in Q1 2018.
- Carillon Tower Advisers's portfolio value rose 136,756% quarter-over-quarter to $12.9B.
Based on Carillon Tower Advisers's 13F filing for Q1 2018, filed 14 May 2018.